From the

HIMSS18 Round-up: Why the Time for Precision Medicine is Now

Key takeaways from HIMSS18 reinforce how important it is to build foundations for precision medicine now.

PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution

PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today a partnership with Cancer Genetics, Inc. (CGI) (Nasdaq: CGIX) to provide a […]

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace […]

PierianDx Exhibiting at Health Systems Summit

PierianDx will be exhibiting at an intensive one-day summit for CEOs and hospital administrators of health systems. “Precision Medicine for Hospital CEOs: What You Need to Know about Genetic Testing, […]

PierianDx Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing

PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today it will be hosting an expert panel to discuss CMS’s National Coverage […]

PharmaTech Outlook Spotlights PierianDx in December Issue

PharamTech Outlook recently featured PierianDx in it’s December 2017 issue, outlining the groundbreaking role the company has played in advancing NGS testing and precision medicine for healthcare organizations. The article […]

PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening clinical expertise. BG Jones has been named Senior Vice President […]

Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision Medicine

PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patients. “We are excited that […]

PierianDx Accelerates Precision Medicine with Fully Integrated Workflow and Interpretation Solution Supporting Illumina TruSight Tumor 170

PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today it has launched a complete technology and medical interpretation solution to support Illumina’s TruSight Tumor 170 (TST170). PierianDx […]

PierianDx Announces Clinical Microarray Technology Will Be Integrated into its End-to- End Genomics Platform for Clinical Labs

ST LOUIS  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that its leading, integrated “one space” genomics workflow and analysis solution, Clinical Genomicist Workspace (CGW), now […]